Navigation Links
Commercialization of drugs by fast tracking is a cause of concern

A senior doctor has by the means of BMJ raised a serious concern over licensing of new drugs for commercialization purposes. //

This has come after natalizumab, a new drug for multiple sclerosis, was approved and thereafter recalled after three months. This was done after three trial patients developed a life threatening condition while being treated.

The drug was licensed by the US Food and Drug Administration in 2004 on the basis of short term results from two unpublished trials. The result was that when tested it was on 28 February 2005, recalled after three trial patients developed progressive multifocal leucoencephalopathy (PML). The result was that in between two of the patients died.

The approval of natalizumab and its recall after three months raises questions about the fast tracking of new drugs by the FDA for commercial licensing. This was brought to the fore by consultant neurologist Abhijit Chaudhuri.

The warning signal is here and it must be paid heed to so that in the future such mistakes are not repeated.


Page: 1

Related medicine news :

1. Commercialization of Biotech Discoveries, An Encouragement For Researchers
2. Cancer drugs in development nearly doubled since 1995
3. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
4. African HIV strains more resistant to anti HIV drugs
5. Right drugs drastically cut stroke risk
6. Relating heart protection and antihypertensive drugs
7. Enzyme may be target for obesity drugs
8. New HIV cases resist drugs
9. Relief to pregnant women using fertility drugs
10. AIDS drugs linked to heart attack risk
11. FDA debates status of decongestant drugs
Post Your Comments:

(Date:6/24/2016)... ... ... crisis. Her son James, eight, was out of control. Prone to extreme mood shifts and ... him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife on ... say he was going to kill them. If we were driving on the freeway, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: